Article Information
History
- April 7, 2021.
Article Versions
- You are currently viewing Version 1 of this article (April 7, 2021 - 19:13).
- Version 2 (May 1, 2021 - 09:36).
- Version 3 (June 11, 2021 - 09:30).
- View Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Matt D.T. Hitchings1,2,*,
- Otavio T. Ranzani3,4,*,
- Mario Sergio Scaramuzzini Torres5,
- Silvano Barbosa de Oliveira6,
- Maria Almiron6,
- Rodrigo Said6,
- Ryan Borg7,8,
- Wade L. Schulz9,10,
- Roberto Dias de Oliveira11,
- Patricia Vieira da Silva12,
- Daniel Barros de Castro13,
- Vanderson de Souza Sampaio13,
- Bernardino Cláudio de Albuquerque13,
- Tatyana Costa Amorim Ramos13,
- Shadia Hussami Hauache Fraxe15,
- Cristiano Fernandes da Costa13,
- Felipe Gomes Naveca17,
- Andre M. Siqueira,
- Wildo Navegantes de Araújo14,
- Jason R. Andrews†,15,
- Derek A.T. Cummings†,1,2,
- Albert I. Ko† and
- Julio Croda9,12,17,†,**
- 1Department of Biology, University of Florida, Gainesville, FL, USA
- 2Emerging Pathogens Institute, University of Florida, Gainesville, FL, USA
- 3Universidade de Sao Paulo, São Paulo, SP, Brazil
- 4Barcelona Institute for Global Health, ISGlobal, Barcelona, Spain
- 5Municipal Health Secretary of Manaus
- 6Pan American Health Organization
- 7Universidade de Brasília, Brasília, DF, Brazil
- 8Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, CT, USA
- 9Center for Outcomes Research and Evaluation, Yale-New Haven Hospital, New Haven, CT, USA
- 10Department of Laboratory Medicine, Yale University School of Medicine, New Haven, CT, USA
- 11State University of Mato Grosso do Sul - UEMS, Dourados, MS, Brazil
- 12Universidade Federal de Mato Grosso do Sul - UFMS, Campo Grande, MS, Brazil
- 13Fundação de Vigilância em Saúde do Estado do Amazonas
- 14Pulmonary Division, Heart Institute (InCor), Hospital das Clinicas HCFMUSP, Faculdade de Medicina, National Institute for Science and Technology for Health Technology Assessment, Porto Alegre, RS, Brazil
- 15Division of Infectious Diseases and Geographic Medicine, Stanford University, Stanford, CA, USA
- 16Instituto Gonçalo Moniz, Fundação Oswaldo Cruz, Salvador, BA, Brazil
- 17Fiocruz Mato Grosso do Sul, Fundação Oswaldo Cruz, Campo Grande, MS, Brazil
- ↵**Corresponding author; email: julio.croda{at}fiocruz.br
Posted April 07, 2021.
Effectiveness of CoronaVac in the setting of high SARS-CoV-2 P.1 variant transmission in Brazil: A test-negative case-control study
